Market Leadership As the first commercial and fully permitted medical cannabis supplier in Washington since 2011, Solstice Group has established a strong market presence and credibility that can be leveraged to expand into new regions or product lines.

Growth Potential With an annual revenue between 10 to 25 million dollars and recent funding of 8 million dollars, the company is positioned for strategic expansion, technology upgrades, and new product development opportunities.

Industry Focus Specializing in high-quality cannabis products with a long-standing operational history, Solstice targets medical cannabis retail channels, indicating opportunities to develop branded consumer products or explore recreational markets.

Partnership Opportunities Given its pioneering status and established infrastructure, Solstice may be interested in technology solutions like supply chain management, compliance systems, and innovative cultivation technologies to enhance efficiency and product quality.

Competitive Edge Operating in a highly regulated and rapidly evolving industry, Solstice’s early market entry and experience could facilitate collaborations with industry players, consultancy services, and expansion into neighboring states or countries with similar regulatory environments.